Vendor Intelligence Report: Sunrise BioResearch

Published 2 Jul 2026. 18-page investigative report on who is behind Sunrise BioResearch: corporate records, ownership, affiliate networks, and the vendor's lab-testing record. The first 3 pages are free to read on this page.

Researched and published by Finnrick Analytics. Reports draw on corporate records, affiliate-network analysis, and Finnrick's own laboratory testing record; vendors can challenge findings through the formal objections process at finnrick.com/vendor-support/objections.

Executive summary

Sunrise BioResearch is a young, traceable-but-thin peptide vendor. Across 4 Finnrick lab tests, Sunrise posts a 75% overall pass rate, with 3 passes and 1 fail. The record is narrow: every Finnrick result is for Tirzepatide, where three passes are offset by one severe certificate recording 0.0% purity. That makes Sunrise neither a catalog-wide failure nor a catalog-wide validation; current non-Tirzepatide products remain unvalidated by Finnrick, and stricter-grading charts are limited by the same dataset.

The paper trail improves on a hidden storefront but stops short of manufacturing traceability. Arizona records identify an LLC and named member, while the operating footprint runs through a PMB-style address, registered-agent service, private domain registration and a domain/site history beginning in mid-2025. The full report separates what is verified from what remains unproven about control, technical background and supply chain.

The most buyer-relevant issue is what happened after the bad Tirzepatide result. Sunrise promotes public COAs, but the captured shop and certification pages no longer show Tirzepatide, and the dossier found no public recall, batch explanation or customer notice. If Tirzepatide reappears, the bar is not brand trust; it is lot-matched, independently verifiable replacement evidence.

Promotion adds a second governance signal. The investigation maps a loose referral ecosystem: Peptides4Power, X posts, Reddit referral links and coupon paths, with referral/coupon records lacking clear disclosures in the captured scan. Community praise exists, but the report treats it as service sentiment, not vial-identity evidence.

Inside the full report:

  • Finnrick lab certificate, rating trajectory and methodology-divergence charts for the tested Tirzepatide record
  • Arizona LLC filing trail, PMB/registered-agent footprint and redacted WHOIS/domain timeline
  • Shop and COA-page comparison showing the current absence of Tirzepatide records after the failed certificate
  • Affiliate and coupon-link sweep covering Peptides4Power, X, Reddit and coupon sites
  • Reputation, brand-confusion and buyer-verification analysis for avoiding similarly named vendors

Risk assessment

  • Tirzepatide quality-control and post-failure transparency risk — high: Finnrick certificate for Tirzepatide 20mg batch glp320feb26-01 recorded 0.0% purity; the product is absent from current shop/COA pages with no recall or explanation identified.
  • Operational traceability concern — medium: Sunrise Bioresearch LLC formed June 19, 2025; public footprint uses a PMB, registered-agent service and redacted WHOIS, with only Sean Kolling identified in filings.
  • Undisclosed affiliate-promotion risk — medium: Affiliate scan found referral links/codes on X, Reddit and coupon sites, including roeklyxn, Rory, PEPTI, SUNRISE and SUMMER, with no clear disclosures; Peptides4Power promotes POWER15.
  • Brand-confusion and authenticity-verification risk — medium: Community users explicitly distinguish Sunrise BioResearch from similarly named Sunrise Peptides; materials did not identify an official reseller list or anti-counterfeit verification program.